Recently, the first orally administered GLP-1 analogue was approved for the treatment of T2DM
The product resembles liquid gold, when applied, it dries, transferring beneficial substances to the deeper layers of the skin, and then is removed with a uniform film, stretching the contents of the pores, eliminating bacteria and dead cells
A 2021 randomized controlled trial demonstrated that exenatide, a GLP-1 receptor agonist, significantly slowed cognitive decline in patients with early-stage Parkinsons disease compared to a placebo group (Athauda et al., 2021)
Avoid storing vials where sunlight reaches, even indirect light through windows can accelerate breakdown
[03:48] Brigham Yeah, and me too